Sort
48,018 grants matching “immunotherapy”
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
$535,816Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
Project 3-Cancer cell interaction with oncogenic type 1 collagen in PDAC
$535,815Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
$535,778Jianjun Gao · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
$535,778Jianjun Gao · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
$535,778Jianjun Gao · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response
$535,758Melissa B Davis · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Cyclin Dependent Kinases as Epigenetic Therapy Targets
$535,736Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2025 · CA
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
$535,708Michael Karin · University Of California, San Diego · R01 · FY2024 · CA
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$535,638Wei R. Chen · University Of Oklahoma · R01 · FY2022 · CA
Escape from CAR T surveillance through lineage plasticity
$535,637Patricia A Ernst · University Of Colorado Denver · R01 · FY2024 · CA
A novel signaling mechanism for LRP5
$535,605Dianqing Wu · Yale University · R01 · FY2023 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$535,530Jinming Gao · Ut Southwestern Medical Center · U01 · FY2021 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$535,530Jinming Gao · Ut Southwestern Medical Center · U01 · FY2018 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$535,530Jinming Gao · Ut Southwestern Medical Center · U01 · FY2017 · CA
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$535,514David B Shackelford · University Of California Los Angeles · R01 · FY2022 · CA
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$535,514David B Shackelford · University Of California Los Angeles · R01 · FY2025 · CA
Regulation of Lymphocyte Proliferation and Replicative Capacity
$535,509Richard J. Hodes · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Identifying the mechanism of anti-colorectal immunity induced by mucoinvasive colonic bacteria
$535,501Timothy Wesley Hand · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Safer lung cancer radiotherapy delivery using novel artificial intelligence methods
$535,474Harini Veeraraghavan · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Molecular and Cellular Immunology
$535,455Jason G. Cyster · University Of California, San Francisco · T32 · FY2019 · AI
Targeting HER2-low breast cancer with 17p loss
$535,448Xiongbin Lu · Indiana University Indianapolis · R01 · FY2021 · CA
Engineered Nanoformulation for Immune-modulation in Cancer
$535,400Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · CA
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation
$535,356Samuel Strober · Stanford University · P01 · FY2017 · HL
Genomics and Functional Characterization of NF1-mutated Lung Cancer
$535,334Eric Collisson · University Of California, San Francisco · R01 · FY2022 · CA
Elucidating Mechanism of Immune Evasion in Head and Neck Cancers
$535,210Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DE